Pascaline Aime-Wilson

Company: Regeneron Pharmaceuticals Inc

Job title: Associate Director, Neuroscience

Seminars:

SNCA-targeting siRNAs Prevent Disease Progression in a Synucleinopathy Mouse Model 11:00 am

Validating efficacy of siRNA in halting dopaminergic neurodegeneration in murine models, mitigating pathological effects associated with SNCA aggregation Evaluating the potential of siRNAs in preventing disease progression in synucleinopathy to improve motor function, reduce neuroinflammation or preserve DA neurons Preclinical validation of reduced siRNA toxicity to ensure safe treatment of neurodegenerationRead more

day: Conference Day Two